Emergent BioSolutions
EBS
#7686
Rank
NZ$0.68 B
Marketcap
NZ$13.27
Share price
-6.51%
Change (1 day)
28.65%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2025 (TTM): NZ$2.47

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is NZ$2.41. In 2024 the company made an earnings per share (EPS) of NZ-$6.22 an increase over its 2023 EPS that were of NZ-$25.48.

EPS history for Emergent BioSolutions from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$2.47-139.76%
2024NZ-$6.22-75.61%
2023NZ-$25.48232.21%
2022NZ-$7.67-203.46%
2021NZ$7.41-25.09%
2020NZ$9.90445.28%
2019NZ$1.82-15.2%
2018NZ$2.14-35.9%
2017NZ$3.3469.57%
2016NZ$1.97-27.67%
2015NZ$2.7265.63%
2014NZ$1.6411.63%
2013NZ$1.4732.31%
2012NZ$1.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.24-7.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.09 152.29%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.65 175.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
NZ-$5.55-329.79%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.72-70.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.66-375.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.35-2.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel